EGHYA: Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm
Study Details
Study Description
Brief Summary
The aim of this study is to demonstrate the efficacy of an algorithm to anticipate the post prandial glycemic profile in type I diabetic patient.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Algorithm efficacy [15 days]
The Algorithm efficacy in predicting the risk or absence of risk of hyperglycemia two hours after taking a full meal is evaluated by comparing glycemic values calculated by the algorithm and those obtained using continuous glucose monitoring system measurements.
Secondary Outcome Measures
- Algorithm efficacy (lower margin of error) [15 days]
The Algorithm efficacy in predicting the risk or absence of risk of hyperglycemia two hours after taking a full meal is evaluated by comparing glycemic values calculated by the algorithm and those obtained using continuous glucose monitoring system measurements (the accepted margin of error is reduced by 25 to 50% when compared with primary outcome).
- Algorithm efficacy versus meal composition [15 days]
Meals will be analyzed within different groups according to their respective nutritional index. For each group, algorithm prediction reliability will be determined.
- Influence of the age of the patients on algorithm results [15 days]
The Algorithm efficacy will be analyzed according to the age of patients
- Influence of the BMI on algorithms results [15 days]
Weight and height of patients will be combined to report BMI in kg/m2. Algorithm efficacy will be analyzed according to the BMI of patients
- Influence of the insulin administration on algorithm results [15 days]
Data obtained from patients using insulin pumps will be compared to data obtained from patients using multiple daily insulin injections.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Type 1 diabetes
-
≥ 18 years old
-
Hb1Ac<12%
Exclusion Criteria:
-
Patient without continuous glucose monitoring system
-
Disease other than diabetes (bulimia, anorexia…)
-
Dialysis patient
-
Known history of drug or alcohol abuse
-
Patient under judicial protection
-
Person deprived of liberty
-
Pregnant, parturient or breastfeeding woman
-
Patient in psychiatric care
-
Patient admitted to a health or social institution for purposes other than research
-
Any reasons that might interfere with the evaluation of the study objectives
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | APHM | Marseille | France | ||
2 | Hopital Sainte Musse | Toulon | France |
Sponsors and Collaborators
- M-DT1
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Assistance Publique Hopitaux De Marseille
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-MDT1-001
- 2021-AO2599-32